Literature DB >> 12225284

Linezolid-induced neuropathy.

Carmela E Corallo, Amalie E Paull.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12225284

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  9 in total

1.  Linezolid induced toxic optic neuropathy.

Authors:  K Kulkarni; L V Del Priore
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

2.  Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.

Authors:  N Duewelhenke; O Krut; P Eysel
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

Review 3.  Linezolid-induced optic neuropathy: a mitochondrial disorder?

Authors:  M Javaheri; R N Khurana; T M O'hearn; M M Lai; A A Sadun
Journal:  Br J Ophthalmol       Date:  2007-01       Impact factor: 4.638

Review 4.  Use of pharmacodynamic principles to optimise dosage regimens for antibacterial agents in the elderly.

Authors:  Ayman M Noreddin; Virginia Haynes
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 5.  Newer treatment options for skin and soft tissue infections.

Authors:  Murugan Raghavan; Peter K Linden
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Linezolid-associated optic neuropathy in a patient with ocular sarcoidosis.

Authors:  Katsuji Kiuchi; Miki Miyashiro; Chiemi Kitagawa; Sanae Wada
Journal:  Jpn J Ophthalmol       Date:  2009-09-08       Impact factor: 2.447

Review 7.  Benefit-risk assessment of linezolid for serious gram-positive bacterial infections.

Authors:  Matthew E Falagas; Konstantinos Z Vardakas
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 8.  Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.

Authors:  Claire Roger; Jason A Roberts; Laurent Muller
Journal:  Clin Pharmacokinet       Date:  2018-05       Impact factor: 6.447

9.  Safety of long-term use of linezolid: results of an open-label study.

Authors:  Jose A Vazquez; Anthony C Arnold; Robert N Swanson; Pinaki Biswas; Matteo Bassetti
Journal:  Ther Clin Risk Manag       Date:  2016-09-01       Impact factor: 2.423
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.